Alliance Pharma PLC Notification of Preliminary Results (2761Y)

TIDMAPH

RNS Number : 2761Y

Alliance Pharma PLC

02 March 2017

 
 For immediate release                    2 March 2017 
 

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Notification of Preliminary Results

Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, will announce its preliminary results for the year ended 31 December 2016 on Wednesday 29 March 2017.

A briefing for analysts will be held at 10.00am on the morning of the results at the offices of Buchanan, 107 Cheapside, London EC2V 6DN.

For more information please contact Buchanan on 020 7466 5000.

For further information:

 
 Alliance Pharma plc                             + 44 (0) 1249 466966 
 John Dawson, Chief Executive 
  Andrew Franklin, Chief Financial 
  Officer 
 www.alliancepharma.co.uk 
                                                     + 44 (0) 20 7466 
 Buchanan                                                        5000 
 Mark Court / Sophie Cowles 
  / Jane Glover 
 
                                                     + 44 (0) 20 7260 
 Numis Securities Limited                                        1000 
 Nominated Adviser: Michael 
  Meade / Freddie Barnfield 
 Corporate Broking: James 
  Black / Toby Adcock 
 

Notes to editors:

About Alliance Pharma

Alliance, founded in 1998, is an international speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has sales in more than 100 countries worldwide via direct sales, joint ventures and a network of distributors. Alliance has a strong track record of acquiring the rights to established niche products and it currently owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The Company continues to explore opportunities to expand its product portfolio.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORLLFVRVDILIID

(END) Dow Jones Newswires

March 02, 2017 02:01 ET (07:01 GMT)